Buy more Mobic and Save more.

Wireless News

02-01-2006

LDR Spine Gets FDA Approval to Conduct Clinical Trial for a Second- Generation Cervical Artificial Disc

WIRELESS NEWS-February 1, 2006-LDR Spine Gets FDA Approval to Conduct…

THE PAINKILLER Mobic saw sharp gains in new users in the days following Pfizer’s withdrawal of COX-2 drug Bextra.
In the week ending April 8, nearly 25 percent of former Bextra patients switched to Mobic, which is jointly marketed by Abbott Laboratories and Boehringer Ingelheim, according to data from Verispan’s Vector One.
Bear Stearns analyst Rick Wise said in published repo…

Related Results

MobicMobicMobic approvalMobic escapes boxed warning.MOBIC - Brief Article

> The Food and Drug Administration has approved the use of Mobic as a treatment for rheumatoid arthritis. Boehringer Ingelheim Inc. launched the drug four years ago for treating osteoarthritis, the most comm…

The Food and Drug Administration has approved the first generic versions of Mobic (meloxicam) for the treatment of osteoarthritis. The new approvals of 13 generic meloxicam applications stem from the agency’s cluster review approach, aimed at increasing efficiency and decreasing review time for generic drugs.

Related Results

MobicMobicMobic approvalMobic escapes boxed warning.MOBIC - Brief Article

In the case of meloxicam, …

The real breakthrough was when the COX-2 inhibiting nonsteroidal anti-inflammatory drugs (NSAIDs) first emerged. First was Celebrex. Next came Vioxx. Now there is Mobic (or meloxicam) for the treatment of the symptoms of osteoarthritis. For those who suffer chronic arthritis pain, these drugs were a true innovation. The first generation of NSAIDs…

Jun 26, 2005 (The Mercury - ABIX via COMTEX)

Related Results

MobicMobicMobic approvalMobic escapes boxed warning.MOBIC - Brief Article

Concerns are being raised about some of the most commonly used medicines in Australia. The arthritis drug Vioxx was withdrawn from sale in 2004, because trials indicated an increased risk of heart attack and s…

The FDA has approved several generic versions of Boehringer Ingelheim’s Mobic (meloxicam) tablets. Meloxicam is indicated for the treatment of osteoarthritis.
“This is another example of our agency’s endeavor to counter rising health care costs by approving safe and effective generic alternatives to brand name drugs,” Gary Buehler, director of the FDA’s Office of Generic Drugs (OGD), said in announcing the July 2006 approval. “Meloxicam is a widely-…

The most common type of arthritis is osteoarthritis (OA). This article discusses the diagnosis and management of this common problem.

Osteoarthritis (OA) of the knee is one of the most common causes of knee pain in people over the age of 30. The cause is progressive wearing away of the cartilage cushion that covers the ends of the long bones that make up the knee joint. The inflammation that accompanies this process…

About WebMD
WebMD Health Corp. (Nasdaq: WBMD) is the leading provider of health information services, serving consumers, physicians, healthcare professionals, employers and health plans through our public and private online portals and health-focused publications. WebMD is a subsidiary of Emdeon Corporation (Nasdaq: HLTH). The WebMD Health Network reaches approximately 30 million visitors a month through its leading owned and operated health sites t…

The latest figures show that roughly 43 million American adults–about 1-in-5–have arthritis diagnosed by a doctor, making it the leading cause of disability in the United States. This number is projected to increase to 67 million by 2030.
Each yea…